[Prevalence and related risk factors of hypertensive patients with co-morbid anxiety and/or depression in community: a cross-sectional study].
OBJECTIVE
To explore the prevalence of hypertensive patients with co-morbid anxiety and/or depression and determine the risk factors of comorbidity in community.


METHODS
A cross-section study was performed among 807 hypertensive patients in urban and rural community settings of Beijing in 2011. The Composite International Diagnostic Interview, computer assisted personal interview (CIDI-3.0-CAPI) was administrated by face-to-face interview. And the diagnosis of anxiety and depression was made according to the definitions and criteria of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DMS-IV). The prevalence and related risk factors of hypertensive patients with comorbid anxiety and/or depression were reported.


RESULTS
It was found that 23.3% of patients were accompanied with anxiety and 5.7% with depression in hypertensive patients in community. The risk factors of anxiety included irregular treatment (odds ratio 4.500; 95% confidence interval, 2.431 to 8.331), smoking (1.805; 1.036 to 3.145), manual labor (1.933; 1.223 to 3.053) and two or above stage of hypertension (1.525; 1.041 to 2.234). And the risk factors of depression included irregular treatment (5.333; 1.554 to 18.304), taking reserpine or ingredients containing reserpine (6.667; 1.981 to 22.435) and singlehood (5.000; 1.096 to 22.820).


CONCLUSIONS
The prevalence of anxiety is higher than depression in hypertensive patients in community. Irregular treatment is the common risk factor of anxiety and depression. Patients with smoking, manual labor and two or above stage of hypertension are more likely to have a coexistence of anxiety while those unmarried, taking reserpine or ingredients containing reserpine are more likely to suffer from depression.
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Jinmin
J
Liao
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China. Email:xilinwang@126.com.
Xilin
X
Wang
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Cui
C
Liu
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Zhaoxia
Z
Gu
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Lijun
L
Sun
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Yanbo
Y
Zhang
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Yueqin
Y
Huang
Peking University Institute of Mental Health, Key Laboratory of Mental Health, Ministry of Health (Peking University), Beijing 100191, China.
Zhaorui
Z
Liu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001008:Anxiety Disorders / Q000453:epidemiology*; D002681:China / Q000453:epidemiology; D003430:Cross-Sectional Studies; D003866:Depressive Disorder / Q000453:epidemiology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D055815:Young Adult